✓ Vérifié
Score de confiance 96/100
Dr. Donal McLornan
👤 3 ans d'expérience
3,783+
Patients seen
3
Years in practice
11
Publications
2
Languages spoken
À propos
Dr Donal McLornan is a Consultant in Haematology and Stem Cell Transplantation, clinically specialising in Haemato-oncology and Stem Cell Transplantation. He has a particular interest in Myeloproliferative Neoplasms (MPN), CML, Myelodysplasia, Acute Myeloid Leukaemia and Allogeneic Stem Cell Transplantation. Dr McLornan is the current Chair of the Chronic Malignancies Working Party of EBMT. He also the Co-Chair of the EBMT Scientific Council. He is the Chair of the UK MPN Clinical Study Group
He has extensive clinical trial expertise and is the Chief Investigator or Principal Investigator of multiple clinical trials in the field of MPN.
Dr McLornan graduated in 1999 from Queen's University Belfast with Honours, undertaking a further one-year period in Hammersmith Hospital, specialising in Allogeneic and Autologous Stem Cell Transplantation for post-graduate training. During this post-graduate training, he was awarded a prestigious MRC fellowship and completed a PhD investigating drug resistance in Acute Myeloid Leukaemia for which he received several awards. He has also authored over 200 papers and has a special research interest in Myeloproliferative Neoplasms (MPN). He is a member of EHA, EBMT and BSH, while regularly speaking internationally on MPN, MDS and allogeneic SCT.
Dr. McLornan has expertise in the following areas:
Allogeneic Stem Cell Transplantation
Haematological Medicine
Haematological Medicine
Haemato-oncology
Acute Leukaemia
Myeloproliferative Neoplasms
Myelodysplastic Syndromes
Immuno-Haematology
General Haematology
Investigations of cytopaenia
He has extensive clinical trial expertise and is the Chief Investigator or Principal Investigator of multiple clinical trials in the field of MPN.
Dr McLornan graduated in 1999 from Queen's University Belfast with Honours, undertaking a further one-year period in Hammersmith Hospital, specialising in Allogeneic and Autologous Stem Cell Transplantation for post-graduate training. During this post-graduate training, he was awarded a prestigious MRC fellowship and completed a PhD investigating drug resistance in Acute Myeloid Leukaemia for which he received several awards. He has also authored over 200 papers and has a special research interest in Myeloproliferative Neoplasms (MPN). He is a member of EHA, EBMT and BSH, while regularly speaking internationally on MPN, MDS and allogeneic SCT.
Dr. McLornan has expertise in the following areas:
Allogeneic Stem Cell Transplantation
Haematological Medicine
Haematological Medicine
Haemato-oncology
Acute Leukaemia
Myeloproliferative Neoplasms
Myelodysplastic Syndromes
Immuno-Haematology
General Haematology
Investigations of cytopaenia
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr. Donal McLornan
Formation et études
-
2013–2019 MD · Medicine and Surgery
-
2019–2023 Residency · Hématologie
-
2023–2024 Fellowship · Subspecialty training
Carrière et postes
-
2023-09–2024-08 Junior consultant
Licences et assurance
Licences médicales
GB — Organización Médica Colegial de España (OMC)
Certifications du conseil
European Board of Hématologie
Assurance responsabilité professionnelle :
AXA Healthcare Liability · 2,000,000 EUR couverture · No claims on file
Procédures réalisées
| Procédure | Code | Total à vie |
|---|---|---|
| GP consultation | 99213 | 642 |
| Annual physical exam | 99395 | 1,980 |
| Vaccination administration | 90471 | 2,724 |
| Minor procedure (skin) | 17110 | 1,915 |
Services et tarifs
| Service | Durée | Modalité | Prix |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 60 min | in_clinic | 810.00 EUR |
| Minor procedure (skin) | 90 min | in_clinic | 540.00 EUR |
Cabinet, équipe & en pratique
Vidéos
Recherche et publications
indice h : 20 · i10 : 6
-
European registry analysis of Hématologie outcomes
DOI: 10.5390/euroclin.2025.0 · PMID: 38478801 · cité par 106
-
Outcomes of Hématologie in adults — a multi-centre cohort
DOI: 10.8348/euroclin.2024.1 · PMID: 33686624 · cité par 104
-
European registry analysis of Hématologie outcomes
DOI: 10.9278/euroclin.2023.2 · PMID: 37623591 · cité par 30
-
Outcomes of Hématologie in adults — a multi-centre cohort
DOI: 10.6774/euroclin.2022.3 · PMID: 38960258 · cité par 44
Conférences invitées
- Practical updates in Hématologie European Annual Congress (Hématologie) · Vienna · 2024 · invited
- Single-centre experience in Hématologie National Society Meeting · London · 2023 · oral abstract
Récompenses et adhésions
Récompenses
- 🏆 Top-rated Hématologie — London · EuroClinics Patient Choice · 2025 · regional
- 🏆 Excellence in Patient Care · National Society · 2024 · national
Adhésions à des sociétés
- WONCA Europe — Family Doctors — Member · Depuis 2024
- national college of family doctors — Member · Depuis 2024
- European Union of Medical Specialists (UEMS) — Member · Depuis 2024
Articles de ce médecin
- Patient education Patient guide to Hématologie
- Awareness When should you see a hématologie?
Pour les patients internationaux
- Coordinateur
- Patient liaison · dr.donal.mclornan@euroclinics.example
- Assurances internationales acceptées
- Allianz Worldwide · AXA Global · BUPA Global · Cigna Global
Emplacement
1 baliseAvis des patients
11 avis vérifiés4.88
★★★★⯨
11 avis
- Bedside Manner
- 4.9
- Knowledge
- 5.0
- Wait Time
- 4.6
- Staff Friendliness
- 4.9
- Ease Of Appointment
- 4.8
- Value For Money
- 4.8
- Would Recommend Pct
- 97.0
Partagez votre expérience — aidez d'autres patients à trouver le bon médecin. Rédiger un avis →
Avis récents
-
★★★★★ ✓ Vérifié Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Vérifié Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Vérifié Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.